Today, the neurosciences enjoy a similar prestige as psychoanalysis in the twentieth century, write Hennric Jokeit and Ewa Hess. Despite the immense costs for healthcare systems, the fear of depression, dementia and attention deficit disorder legitimises the boom in neuro-psychotropic drugs. In a performance-driven society that confronts the self with its own shortcomings, neuroscience serves an expanding market.
Ewa Hess
Germanist, head of the culture department of Sonntagszeitung in Zurich.
